Fundraising Fox
GoodCap
1 known investors
Find your way into GoodCap
Sign up to see every warm intro you have to GoodCap
- Paths you didn't know you had: your email and LinkedIn already hold routes to the GoodCap team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GoodCap Pharmaceuticals develops drug candidates targeting disorders driven by neuroinflammation, with a lead candidate (GCAP001) combining two molecule classes to reduce inflammatory biomarkers linked to psychiatric and neurodegenerative conditions. Its initial focus is on treating PTSD.
Founders & leadership
DH
Darryl HudsonCo-founderDarryl Hudson holds a PhD in Molecular Biology and Genetics and has worked on drug development for inflammation and mental health products. He is co-founder of GoodCap Pharmaceuticals, which develops drug candidates targeting neuroinflammation-driven disorders.
Investors · 1
Frequently asked questions
- What does GoodCap do?
- GoodCap Pharmaceuticals develops drug candidates targeting disorders driven by neuroinflammation, with a lead candidate (GCAP001) combining two molecule classes to reduce inflammatory biomarkers linked to psychiatric and neurodegenerative conditions. Its initial focus is on treating PTSD.
- Who founded GoodCap?
- GoodCap was founded by Darryl Hudson.
- Who are GoodCap's investors?
- GoodCap's investors include JLS.